Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is among the Most Volatile Stocks. On February 6, 2026, TD Cowen upgraded Adaptive Biotechnologies Corporation (NASDAQ:ADPT)’s price target to $21 from $20 while keeping a Buy rating, citing a Q4 beat and an improved outlook. TD Cowen said that community adoption, new indications, pharma guidelines, EMR integrations, and a shift to blood-based testing were major driving factors. On February 6, 2026, BTIG maintained a Buy rating on Adaptive Biotechnologi ...

Mehmet Oz, head of the US Centers for Medicare and Medicaid Services, pledged continued insurance coverage for all recommended vaccinations in the country and urged people to get the measles shot as infections skyrocket https://t.co/zTQULGasq2 ...